May 29, 2018
Applied Clinical Trials
Here are four trends to watch as researchers continue to make headway in the development of biomarkers for cancer immunotherapy.
Dec 18, 2017
Applied Clinical Trials
Until more sophisticated measures are created, a combination of investigator training and new imaging methods is the best way to create accurate, reproducible data across sites.
Nov 28, 2017
Applied Clinical Trials
Sponsors can streamline the design and execution of their clinical trials by following this three-step approach.
Sep 13, 2017
Applied Clinical Trials
Due to a shifting landscape because of faster drug approvals, this article offers strategies for sponsors to design clinical trials.
Mar 27, 2017
In the search for more effective treatments and cures, there are challenges that sponsors and CROs must confront when conducting IMID clinical trials.
Feb 23, 2017
Drug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.
Sep 28, 2016
While block randomization has been shown to be a more frequently used form of trial randomization design, the use of dynamic randomization has been shown to have optimal treatment group balancing results.
Sep 12, 2016
Immunotherapy drugs have led to successes in the oncology space as the list of cancer survivors continues to grow. However, more work must be done to ensure that all patients who can benefit from these life-saving drugs receive them.
Jun 20, 2016
Progress and innovation within oncology has accelerated to a paradigm that includes immunotherapy and bio-genomics. Collaborative approaches in the future will continue to transform treatments in hopes of improving patient quality of life.
Feb 22, 2016
With significant technology advances in ECG recording through the years, the need to expand on traditional monitoring baselines—and include new variables such as time when designing clinical trial protocols—is important.
native1_300x100
lorem ipsum